Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Biomarkers | Research

Salivary macrophage chemokines as potential biomarkers of gingivitis

Authors: Amna Alhammadi, Aghila Rani Koippallil Gopalakrishnan, Roba Saqan, Zahi Badran, Sausan Al Kawas, Betul Rahman

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Objective

The present study aimed to analyze the salivary levels of macrophage-activating factor (MAF), macrophage-chemotactic factor (MCF), and macrophage migration inhibitory factor (MIF) in healthy and gingivitis patients, and to correlate between the concentrations of these chemo attractants with the intensity of gingival inflammation clinically.

Methods

Sixty saliva specimens were collected from periodontally healthy (n = 30), and gingivitis patients (n = 30). Bleeding on probing (BOP), Visible Plaque Index (VPI), and Simplified Modified Gingival Index (SMGI) were recorded through clinical examination. Salivary MAF, MCF, and MIF concentrations were assayed using enzyme-linked immunosorbent assays (ELISA). Statistical analysis was performed using SPSS (version 28). Total mean score for each biomarker was determined, and descriptive bivariate statistics were conducted to characterize the levels of biomarkers among the study groups. The difference in the biomarker levels among the study groups were analyzed by independent sample t test and one-way ANOVA. The diagnostic ability of the biomarkers was further tested by ROC curve analysis.

Results

Salivary levels of MAF was not significantly different between periodontally healthy individuals and gingivitis patients. The difference in MCF and MIF levels between patients with gingivitis and those with healthy periodontium was statistically significant (p 0.05 and p 0.001, respectively). When examined across the various stages of disease progression, MIF showed statistically significant difference among the three biomarkers (p 0.05). ROC curve analysis further revealed that area under the curve (AUC) for MIF has a better diagnostic capacity than MCF (AUC 0.981 vs. 0.673).

Conclusions

Our results suggest that MIF could be considered as a potential salivary biomarker for gingivitis.
Literature
1.
go back to reference Marya A, Rokaya D, Heboyan A, Fernandes GVO. Biomolecular and biochemical aspects of the oral cavity. Molecules. 2022;27(24):8676.CrossRef Marya A, Rokaya D, Heboyan A, Fernandes GVO. Biomolecular and biochemical aspects of the oral cavity. Molecules. 2022;27(24):8676.CrossRef
2.
go back to reference Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89(Suppl 1):S74-s84.CrossRef Chapple ILC, Mealey BL, Van Dyke TE, Bartold PM, Dommisch H, Eickholz P, Geisinger ML, Genco RJ, Glogauer M, Goldstein M, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: consensus report of workgroup 1 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89(Suppl 1):S74-s84.CrossRef
3.
go back to reference Srimaneepong V, Heboyan A, Zafar MS, Khurshid Z, Marya A, Fernandes GVO, Rokaya D. Fixed prosthetic restorations and periodontal health: a narrative review. J Funct Biomater. 2022;13(1):15.CrossRef Srimaneepong V, Heboyan A, Zafar MS, Khurshid Z, Marya A, Fernandes GVO, Rokaya D. Fixed prosthetic restorations and periodontal health: a narrative review. J Funct Biomater. 2022;13(1):15.CrossRef
4.
go back to reference Ebersole JL, Nagarajan R, Akers D, Miller CS. Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Front Cell Infect Microbiol. 2015;5:62.CrossRef Ebersole JL, Nagarajan R, Akers D, Miller CS. Targeted salivary biomarkers for discrimination of periodontal health and disease(s). Front Cell Infect Microbiol. 2015;5:62.CrossRef
5.
go back to reference Kaczor-Urbanowicz KE, Trivedi HM, Lima PO, Camargo PM, Giannobile WV, Grogan TR, Gleber-Netto FO, Whiteman Y, Li F, Lee HJ, et al. Salivary exRNA biomarkers to detect gingivitis and monitor disease regression. J Clin Periodontol. 2018;45(7):806–17.CrossRef Kaczor-Urbanowicz KE, Trivedi HM, Lima PO, Camargo PM, Giannobile WV, Grogan TR, Gleber-Netto FO, Whiteman Y, Li F, Lee HJ, et al. Salivary exRNA biomarkers to detect gingivitis and monitor disease regression. J Clin Periodontol. 2018;45(7):806–17.CrossRef
6.
go back to reference Isola G, Santonocito S, Distefano A, Polizzi A, Vaccaro M, Raciti G, Alibrandi A, Li Volti G. Impact of periodontitis on gingival crevicular fluid miRNAs profiles associated with cardiovascular disease risk. J Periodontal Res. 2023;58(1):165–74.CrossRef Isola G, Santonocito S, Distefano A, Polizzi A, Vaccaro M, Raciti G, Alibrandi A, Li Volti G. Impact of periodontitis on gingival crevicular fluid miRNAs profiles associated with cardiovascular disease risk. J Periodontal Res. 2023;58(1):165–74.CrossRef
7.
go back to reference Sharma A, Goyal R, Sharma L. Potential biological efficacy of Pinus plant species against oxidative, inflammatory and microbial disorders. BMC Complement Altern Med. 2016;16:35.CrossRef Sharma A, Goyal R, Sharma L. Potential biological efficacy of Pinus plant species against oxidative, inflammatory and microbial disorders. BMC Complement Altern Med. 2016;16:35.CrossRef
8.
go back to reference Schätzle M, Faddy MJ, Cullinan MP, Seymour GJ, Lang NP, Bürgin W, Anerud A, Boysen H, Löe H. The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease. J Clin Periodontol. 2009;36(5):365–71.CrossRef Schätzle M, Faddy MJ, Cullinan MP, Seymour GJ, Lang NP, Bürgin W, Anerud A, Boysen H, Löe H. The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease. J Clin Periodontol. 2009;36(5):365–71.CrossRef
9.
go back to reference Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(8 Suppl):1569–76.CrossRef Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol. 2008;79(8 Suppl):1569–76.CrossRef
10.
go back to reference Ti YF, Wang R, Zhao JN. Mechanism of osteoclast in bone resorption. Zhongguo Gu Shang. 2014;27(6):529–32. Ti YF, Wang R, Zhao JN. Mechanism of osteoclast in bone resorption. Zhongguo Gu Shang. 2014;27(6):529–32.
11.
go back to reference Feller L, Altini M, Khammissa RA, Chandran R, Bouckaert M, Lemmer J. Oral mucosal immunity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):576–83.CrossRef Feller L, Altini M, Khammissa RA, Chandran R, Bouckaert M, Lemmer J. Oral mucosal immunity. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(5):576–83.CrossRef
12.
13.
go back to reference Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014;2(1):1.CrossRef Yang J, Zhang L, Yu C, Yang XF, Wang H. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res. 2014;2(1):1.CrossRef
14.
go back to reference Liu YC, Zou XB, Chai YF, Yao YM. Macrophage polarization in inflammatory diseases. Int J Biol Sci. 2014;10(5):520–9.CrossRef Liu YC, Zou XB, Chai YF, Yao YM. Macrophage polarization in inflammatory diseases. Int J Biol Sci. 2014;10(5):520–9.CrossRef
15.
go back to reference Rückerl D, Allen JE. Macrophage proliferation, provenance, and plasticity in macroparasite infection. Immunol Rev. 2014;262(1):113–33.CrossRef Rückerl D, Allen JE. Macrophage proliferation, provenance, and plasticity in macroparasite infection. Immunol Rev. 2014;262(1):113–33.CrossRef
16.
go back to reference Poole NM, Mamidanna G, Smith RA, Coons LB, Cole JA. Prostaglandin E(2) in tick saliva regulates macrophage cell migration and cytokine profile. Parasit Vectors. 2013;6(1):261.CrossRef Poole NM, Mamidanna G, Smith RA, Coons LB, Cole JA. Prostaglandin E(2) in tick saliva regulates macrophage cell migration and cytokine profile. Parasit Vectors. 2013;6(1):261.CrossRef
17.
go back to reference Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491.CrossRef Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491.CrossRef
18.
go back to reference Guimarães MR, Nassar PO, Andia DC, Nassar CA, Spolidorio DM, Rossa C Jr, Spolidorio LC. Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats. Arch Oral Biol. 2007;52(9):882–8.CrossRef Guimarães MR, Nassar PO, Andia DC, Nassar CA, Spolidorio DM, Rossa C Jr, Spolidorio LC. Protective effects of Tacrolimus, a calcineurin inhibitor, in experimental periodontitis in rats. Arch Oral Biol. 2007;52(9):882–8.CrossRef
19.
go back to reference Polizzi A, Santonocito S, Lo Giudice A, Alibrandi A, De Pasquale R, Isola G. Analysis of the response to two pharmacological protocols in patients with oral lichen planus: A randomized clinical trial. Oral Dis. 2023;29(2):755–763. https://doi.org/10.1111/odi.13960. Polizzi A, Santonocito S, Lo Giudice A, Alibrandi A, De Pasquale R, Isola G. Analysis of the response to two pharmacological protocols in patients with oral lichen planus: A randomized clinical trial. Oral Dis. 2023;29(2):755–763. https://​doi.​org/​10.​1111/​odi.​13960.
20.
go back to reference Genco RJ, Slots J. Host responses in periodontal diseases. J Dent Res. 1984;63(3):441–51.CrossRef Genco RJ, Slots J. Host responses in periodontal diseases. J Dent Res. 1984;63(3):441–51.CrossRef
21.
go back to reference Bartold PM, Narayanan AS. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol. 2000;2006(40):29–49. Bartold PM, Narayanan AS. Molecular and cell biology of healthy and diseased periodontal tissues. Periodontol. 2000;2006(40):29–49.
22.
go back to reference Nakajima H, Izumi Y, Sugihara S, Satoh Y, Isumi S, Gotoh T, Fujiwara H, Hamaoka T. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset. Cancer Immunol Immunother. 1987;25(3):201–8.CrossRef Nakajima H, Izumi Y, Sugihara S, Satoh Y, Isumi S, Gotoh T, Fujiwara H, Hamaoka T. Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset. Cancer Immunol Immunother. 1987;25(3):201–8.CrossRef
23.
go back to reference Taniyama T. Macrophage-activating factor (MAF). Nihon Rinsho. 1999;57(Suppl):755–8. Taniyama T. Macrophage-activating factor (MAF). Nihon Rinsho. 1999;57(Suppl):755–8.
24.
go back to reference Fukazawa Y, Kagaya K, Miura H. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: role of mannopyranosyl residue of the MAF molecule in macrophage activation. Microbiol Immunol. 1981;25(11):1163–72.CrossRef Fukazawa Y, Kagaya K, Miura H. Biological and biochemical characterization of macrophage activating factor (MAF) in murine lymphocytes: role of mannopyranosyl residue of the MAF molecule in macrophage activation. Microbiol Immunol. 1981;25(11):1163–72.CrossRef
25.
go back to reference Handa T, Mitsuyama M, Serushago BA, Muramori K, Nomoto K. Co-operative effect of MCF and MAF(IFN-gamma) in the protection of mice against Listeria monocytogenes. Immunology. 1988;65(3):427–32. Handa T, Mitsuyama M, Serushago BA, Muramori K, Nomoto K. Co-operative effect of MCF and MAF(IFN-gamma) in the protection of mice against Listeria monocytogenes. Immunology. 1988;65(3):427–32.
26.
go back to reference Jou IM, Lin CF, Tsai KJ, Wei SJ. Macrophage-mediated inflammatory disorders. Mediators Inflamm. 2013;2013:316482.CrossRef Jou IM, Lin CF, Tsai KJ, Wei SJ. Macrophage-mediated inflammatory disorders. Mediators Inflamm. 2013;2013:316482.CrossRef
27.
go back to reference Ortiz-García YM, García-Iglesias T, Morales-Velazquez G, Lazalde-Ramos BP, Zúñiga-González GM, Ortiz-García RG, Zamora-Perez AL. Macrophage migration inhibitory factor levels in gingival crevicular fluid, saliva, and serum of chronic periodontitis patients. Biomed Res Int. 2019;2019:7850392.CrossRef Ortiz-García YM, García-Iglesias T, Morales-Velazquez G, Lazalde-Ramos BP, Zúñiga-González GM, Ortiz-García RG, Zamora-Perez AL. Macrophage migration inhibitory factor levels in gingival crevicular fluid, saliva, and serum of chronic periodontitis patients. Biomed Res Int. 2019;2019:7850392.CrossRef
28.
go back to reference Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800.CrossRef Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800.CrossRef
29.
go back to reference Liu G, Xu Z, Hao D. MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor. Mol Med Rep. 2016;13(3):2253–60.CrossRef Liu G, Xu Z, Hao D. MicroRNA-451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor. Mol Med Rep. 2016;13(3):2253–60.CrossRef
30.
go back to reference Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001;85(2):162–9.CrossRef Humphrey SP, Williamson RT. A review of saliva: normal composition, flow, and function. J Prosthet Dent. 2001;85(2):162–9.CrossRef
31.
go back to reference Dawood IM, El-Samarrai SK. Saliva and oral health. Int J Adv Res Biol Sci. 2018;5(7):1–45.CrossRef Dawood IM, El-Samarrai SK. Saliva and oral health. Int J Adv Res Biol Sci. 2018;5(7):1–45.CrossRef
32.
go back to reference de Almeida PV, Grégio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008;9(3):72–80.CrossRef de Almeida PV, Grégio AM, Machado MA, de Lima AA, Azevedo LR. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract. 2008;9(3):72–80.CrossRef
33.
go back to reference de Lima V, Bezerra MM, de Menezes Alencar VB, Vidal FD, da Rocha FA, de Castro Brito GA, de Albuquerque RR. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci. 2000;108(2):123–9.CrossRef de Lima V, Bezerra MM, de Menezes Alencar VB, Vidal FD, da Rocha FA, de Castro Brito GA, de Albuquerque RR. Effects of chlorpromazine on alveolar bone loss in experimental periodontal disease in rats. Eur J Oral Sci. 2000;108(2):123–9.CrossRef
34.
go back to reference Rosa N, Correia MJ, Arrais JP, Costa N, Oliveira JL, Barros M. The landscape of protein biomarkers proposed for periodontal disease: markers with functional meaning. Biomed Res Int. 2014;2014:569632.CrossRef Rosa N, Correia MJ, Arrais JP, Costa N, Oliveira JL, Barros M. The landscape of protein biomarkers proposed for periodontal disease: markers with functional meaning. Biomed Res Int. 2014;2014:569632.CrossRef
35.
go back to reference Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(Suppl 11):60–84.CrossRef Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J Clin Periodontol. 2011;38(Suppl 11):60–84.CrossRef
36.
go back to reference Ding C, Ji X, Chen X, Xu Y, Zhong L. TNF-α gene promoter polymorphisms contribute to periodontitis susceptibility: evidence from 46 studies. J Clin Periodontol. 2014;41(8):748–59.CrossRef Ding C, Ji X, Chen X, Xu Y, Zhong L. TNF-α gene promoter polymorphisms contribute to periodontitis susceptibility: evidence from 46 studies. J Clin Periodontol. 2014;41(8):748–59.CrossRef
37.
go back to reference Zhang P, Fan Y, Li Q, Chen J, Zhou W, Luo Y, Zhang J, Su L, Xue X, Zhou X, et al. Macrophage activating factor: a potential biomarker of periodontal health status. Arch Oral Biol. 2016;70:94–9.CrossRef Zhang P, Fan Y, Li Q, Chen J, Zhou W, Luo Y, Zhang J, Su L, Xue X, Zhou X, et al. Macrophage activating factor: a potential biomarker of periodontal health status. Arch Oral Biol. 2016;70:94–9.CrossRef
38.
go back to reference Nonnenmacher C, Helms K, Bacher M, Nüsing RM, Susin C, Mutters R, Flores-de-Jacoby L, Mengel R. Effect of age on gingival crevicular fluid concentrations of MIF and PGE2. J Dent Res. 2009;88(7):639–43.CrossRef Nonnenmacher C, Helms K, Bacher M, Nüsing RM, Susin C, Mutters R, Flores-de-Jacoby L, Mengel R. Effect of age on gingival crevicular fluid concentrations of MIF and PGE2. J Dent Res. 2009;88(7):639–43.CrossRef
39.
go back to reference Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A modified gingival index for use in clinical trials. Clin Prev Dent. 1986;8(1):3–6. Lobene RR, Weatherford T, Ross NM, Lamm RA, Menaker L. A modified gingival index for use in clinical trials. Clin Prev Dent. 1986;8(1):3–6.
40.
go back to reference Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229–35. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J. 1975;25(4):229–35.
41.
go back to reference Syndergaard B, Al-Sabbagh M, Kryscio RJ, Xi J, Ding X, Ebersole JL, Miller CS. Salivary biomarkers associated with gingivitis and response to therapy. J Periodontol. 2014;85(8):e295-303.CrossRef Syndergaard B, Al-Sabbagh M, Kryscio RJ, Xi J, Ding X, Ebersole JL, Miller CS. Salivary biomarkers associated with gingivitis and response to therapy. J Periodontol. 2014;85(8):e295-303.CrossRef
42.
go back to reference Lang NP, Tonetti MS. Periodontal diagnosis in treated periodontitis. Why, when and how to use clinical parameters. J Clin Periodontol. 1996;23(32):240–50.CrossRef Lang NP, Tonetti MS. Periodontal diagnosis in treated periodontitis. Why, when and how to use clinical parameters. J Clin Periodontol. 1996;23(32):240–50.CrossRef
43.
go back to reference Dawes C, Wong DTW. Role of saliva and salivary diagnostics in the advancement of oral health. J Dent Res. 2019;98(2):133–41.CrossRef Dawes C, Wong DTW. Role of saliva and salivary diagnostics in the advancement of oral health. J Dent Res. 2019;98(2):133–41.CrossRef
44.
go back to reference Zhang Y, Kang N, Xue F, Qiao J, Duan J, Chen F, Cai Y. Evaluation of salivary biomarkers for the diagnosis of periodontitis. BMC Oral Health. 2021;21(1):266.CrossRef Zhang Y, Kang N, Xue F, Qiao J, Duan J, Chen F, Cai Y. Evaluation of salivary biomarkers for the diagnosis of periodontitis. BMC Oral Health. 2021;21(1):266.CrossRef
45.
go back to reference Schmalz G, Hübscher AE, Angermann H, Schmidt J, Schmickler J, Legler TJ, Ziebolz D. Associations of chairside salivary aMMP-8 findings with periodontal parameters, potentially periodontal pathogenic bacteria and selected blood parameters in systemically healthy adults. Diagn Microbiol Infect Dis. 2019;95(2):179–84.CrossRef Schmalz G, Hübscher AE, Angermann H, Schmidt J, Schmickler J, Legler TJ, Ziebolz D. Associations of chairside salivary aMMP-8 findings with periodontal parameters, potentially periodontal pathogenic bacteria and selected blood parameters in systemically healthy adults. Diagn Microbiol Infect Dis. 2019;95(2):179–84.CrossRef
46.
go back to reference Zhang D, Xu T, Xu Q, Dong Q, Luo Y, Gao L, Pan Y. Expression profile of macrophage migration inhibitory factor in periodontitis. Arch Oral Biol. 2021;122:105003.CrossRef Zhang D, Xu T, Xu Q, Dong Q, Luo Y, Gao L, Pan Y. Expression profile of macrophage migration inhibitory factor in periodontitis. Arch Oral Biol. 2021;122:105003.CrossRef
47.
go back to reference Gürkan A, Eren G, Çetinkalp Ş, Akçay YD, Emingil G, Atilla G. Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis. Arch Oral Biol. 2016;69:82–8.CrossRef Gürkan A, Eren G, Çetinkalp Ş, Akçay YD, Emingil G, Atilla G. Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis. Arch Oral Biol. 2016;69:82–8.CrossRef
48.
go back to reference Lira-Junior R, Öztürk V, Emingil G, Bostanci N, Boström EA. Salivary and serum markers related to innate immunity in generalized aggressive periodontitis. J Periodontol. 2017;88(12):1339–47.CrossRef Lira-Junior R, Öztürk V, Emingil G, Bostanci N, Boström EA. Salivary and serum markers related to innate immunity in generalized aggressive periodontitis. J Periodontol. 2017;88(12):1339–47.CrossRef
49.
go back to reference Grande MA, Belstrøm D, Damgaard C, Holmstrup P, Könönen E, Gursoy M, Gursoy UK. Salivary concentrations of macrophage activation-related chemokines are influenced by non-surgical periodontal treatment: a 12-week follow-up study. J Oral Microbiol. 2020;12(1):1694383.CrossRef Grande MA, Belstrøm D, Damgaard C, Holmstrup P, Könönen E, Gursoy M, Gursoy UK. Salivary concentrations of macrophage activation-related chemokines are influenced by non-surgical periodontal treatment: a 12-week follow-up study. J Oral Microbiol. 2020;12(1):1694383.CrossRef
50.
go back to reference Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect. 2010;23(4):257–64.CrossRef Grieb G, Merk M, Bernhagen J, Bucala R. Macrophage migration inhibitory factor (MIF): a promising biomarker. Drug News Perspect. 2010;23(4):257–64.CrossRef
Metadata
Title
Salivary macrophage chemokines as potential biomarkers of gingivitis
Authors
Amna Alhammadi
Aghila Rani Koippallil Gopalakrishnan
Roba Saqan
Zahi Badran
Sausan Al Kawas
Betul Rahman
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-02787-5

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue